Digital Solving problems in pathology data, with Nathan Buchbinder Jonah Comstock chats with Nathan Buchbinder, co-founder and chief product officer at Proscia.
Digital Will clinical trials be held in the metaverse? Five ways the... The pronounced success of increased tech adoption in accelerating and streamlining clinical trials over the past few years has opened the floodgates for a slew of new technology and tactics
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
